Study of circulating MicroRNA-125b levels in serum exosomes in advanced melanoma

Archives of Pathology and Laboratory Medicine

Volumn 138, Issue 6, 2014, Pages 828-832

  Alegre, Estibaliz ^a   Sanmamed, Miguel F ^a   Rodriguez, Carmen ^a   Carranza, Omar ^a   Martín Algarra, Salvador ^a   González, Álvaro ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN125 MICRORNA, HUMAN; MIRN16 MICRORNA, HUMAN; RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; DOWN REGULATION; EXOSOME; FEMALE; GENETICS; HUMAN; MALE; MELANOMA; METABOLISM; METASTASIS; MIDDLE AGED;

ADULT; AGED; CASE-CONTROL STUDIES; DOWN-REGULATION; EXOSOMES; FEMALE; HUMANS; MALE; MELANOMA; MICRORNAS; MIDDLE AGED; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 84902438436     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2013-0134-OA     Document Type: Article

References (35)

1. Gray-Schopfer V, Wellbrock C, Marais R. Melanoma biology and new targeted therapy. Nature. 2007;445(7130):851-857
2. Dummer R, Hauschild A, Guggenheim M, Jost L, Pentheroudakis G; ESMO Guidelines Working Group. Melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(supp l 5):v194-v197
3. Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363(8): 711-723
4. Valenti R, Huber V, Iero M, Filipazzi P, Parmiani G, Rivoltini L. Tumorreleased microvesicles as vehicles of immunosuppression. Cancer Res. 2007; 67(7):2912-2915
5. Peinado H, Aleckovic M, Lavotshkin S, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012;18(6):883-891
6. Logozzi M, De Milito A, Lugini L, et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One. 2009;4(4): e5219
7. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5(7):522-531
8. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215-233
9. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435(7043):834-838.
10. Mueller D,Rehli M,Bosserhoff A., miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma , J Invest Dermatol , 2009, 129, 7, 1740-1751.
11. Kappelmann M, Kuphal S, Meister G, Vardimon L, Bosserhoff A-K. MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression. Oncogene. 2013;32(24):2984-2991
12. Chan E, Patel R, Nallur S, et al. MicroRNA signatures differentiate melanoma subtypes. Cell Cycle. 2011;10(11):1845- 1852
13. Glud M, Rossing M, Hother C, et al. Downregulation of miR-125b in metastatic cutaneous malignant melanoma. Melanoma Res. 2010;20(6):479-484
14. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008; 105(30):10513-10518
15. Gallo A, Tandon M, Alevizos I, Illei GG. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One. 2012; 7(3):e30679. doi:10.1371/journal.pone.0030679.
16. Xie L, Chen X, Wang L, et al. Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions. BMC Cancer. 2010; 10(1):591
17. L odes MJ, Caraballo M, Suciu D, Munro S, Kumar A, Anderson B. Detection of Cancer with Serum miRNAs on an Oligonucleotide Microarray. PLoS One. 2009;4(7):e6229. doi: 10.1371/journal.pone.0006229.
18. Brase JC, Johannes M, Schlomm T, et al. Circulating miRNAs are correlated with tumor progression in prostate cancer. Int J Cancer. 2011;128(3):608-616
19. Arroyo JD, C hevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA. 2011;108(12):5003-5008
20. Vickers K C, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by highdensity lipoproteins. Nat Cell Biol. 2011;13(4):423-433
21. Xiao D, Ohlendorf J, Chen Y, et al. Identifying mRNA, MicroRNA and protein profiles of melanoma exosomes. PLoS One. 2012;7(10):e46874. doi1371/journal.pone.0046874
22. Kanemaru H, Fukushima S, Yamashita J, et al. The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker. J Dermatol Sci. 2011;61(3):187-193.
23. Friedman EB, Shang S, de Miera EV, et al. Serum microRNAs as biomarkers for recurrence in melanoma. J Transl Med. 2012;10:155
24. Yuxia M, Zhennan T, Wei Z. Circulating miR-125b is a novel biom arker for screening non-small-cell lung cancer and predicts poor prognosis. J Cancer Res Clin Oncol. 2012;138(12):2045-2050
25. Wang H, Tan G, Dong L, et al. Circulating MiR-125b as a marker pr edicting chemoresistance in breast cancer. PLoS One. 2012;7(4):e34210. doi: 10.1371/journal.pone.0034210
26. Song J, Bai Z, Han W, et al. Identification of Suitable Reference Genes for qPCR Analysis of serum microRNA in gastric cancer patients. Dig Dis Sci. 2012; 57(4):897-904
27. McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A. Analysis of circulating mi croRNA: preanalytical and analytical challenges. Clin Chem. 2011;57(6):833-840
28. Chim SSC , Shing TKF, Hung ECW, et al. Detection and characterization of placental microRNAs in maternal plasma. Clin Chem. 2008;54(3):482-490
29. Miyachi M, Tsuchiya K, Yoshida H, et al . Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma. Biochem Biophys Res Commun. 2010;400(1):89-93
30. Kroh EM, Parkin RK, Mitchell PS, Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods. 2010;50(4):298-301.
31. Taylor D.D., Zacharias W., Gercel-Taylor C., Exosome isolation for proteomic analyses and RNA profiling. Methods Mol Biol, 2011;728,235-246.
32. Spinetti G, Fortunato O, Caporali A, et al. MicroRNA-15a and MicroRNA-16 impair human cir culating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia. Circ Res. 2013;112(2):335-346
33. Nam EJ, Yoon H, Kim SW, et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res. 2008;14(9):2690-2695
34. Visone R, Pallante P, Vecchione A, et al. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene. 2007; 26(54):7590-7595
35. Glud M, Manfe V, Biskup E, et al. MicroRNA miR-125b induces senescence in human melanoma cells. Melanoma Res. 2011;21(3):253-256